Latest News & Features
Big Pharma
Fake drugs cost EU pharmaceutical companies up to €10.2 billion annually, a new report from the European Union Intellectual Property Office has revealed. 29 September 2016
Big Pharma
Biotechnology company Oncodesign is set to acquire pharmaceutical company GSK’s François Hyafil Research Centre in Essonne, France. 29 September 2016
Americas
Biotechnology company Genzyme has sued generic manufacturer Mylan in a lawsuit claiming that the company has infringed one of Genzyme’s patents covering the Clolar injection drug. 28 September 2016
Americas
Amgen has filed a complaint against Indian drug company Micro Labs for allegedly infringing a patent centring on Sensipar. 28 September 2016
Big Pharma
Clifford Chance has hired Stephen Reese as a partner in the firm’s London office. 28 September 2016
Americas
Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture. 28 September 2016
Americas
Drugs company AstraZeneca has filed a patent infringement lawsuit against Par Pharmaceutical. 27 September 2016
Big Pharma
UK-based law firm Potter Clarkson has expanded its intellectual property practice by hiring Nick McDonald and Richard Roberts as a partners and Oliver Laing as a senior associate. 27 September 2016
Americas
India-based pharmaceutical company Glenmark has signed a wide-ranging drug agreement with Particle Sciences, a provider of drug development services. 27 September 2016
Americas
Healthcare company Fresenius Kabi has won a preliminary injunction in a patent infringement lawsuit against a rival company. 27 September 2016